<!DOCTYPE html>
<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>Lymphangiectatic Variant of Low-Grade Malignant Eccrine Spiradenoma.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="Lymphangiectatic Variant of Low-Grade Malignant Eccrine Spiradenoma." class="clickable-image" src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905852/bin/ad-35-71-g003.jpg"/> </div> <div class="text-side"> <h1>Lymphangiectatic Variant of Low-Grade Malignant Eccrine Spiradenoma.</h1> <p>(A) Hyperchromatic cells with mild to moderate atypia, increased mitotic index, nucleolar prominence, loss of polarity, and dual cell population in low-grade malignant eccrine spiradenomas (LGMES). (B, C) Ki-67 and p53 positive cells of LGMES (20% and 80%, respectively). (D) Eccrine spiradenoma (ES) showed dual cell population composed of large cells with pale nuclei arranged in the center and small cells with hyperchromatic nuclei at the periphery. (E, F) Very low Ki-67 and p53 expression in the ES (A~F: H&amp;E, Ã—400).</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36750462/" target="_blank">36750462</a></p><p>Type: Premalignant/Malignant, Category: Adnexal</p>
</div> </div></div></body></html>